Saliva-based Screening Market (2024 - 2034)
Saliva-based Screening Market Analysis by Saliva Collection Kits, Saliva Nucleic Acid Purification Kits, and Saliva Based Detection Kits for Research Use Only and Diagnostics from 2023 to 2034
Core Findings
FREE CustomizationSaliva-based Screening Market Outlook (2024 to 2034)
The global saliva-based screening market is estimated to be worth US$ 374.9 million in 2024. The market is expected to register a CAGR of 8.0% from 2024 to 2034. The market is set to reach a projected value of US$ 810.9 million by 2034.
The demand for saliva-based screening is rising as it offers a promising alternative to blood-based diagnostics. It is a non-invasive and less intrusive method of collecting biological samples. It can be particularly useful in point-of-care settings and remote or underserved areas with limited access to healthcare facilities. Saliva collection is also more straightforward and less time-consuming than traditional blood draws, allowing for more frequent monitoring of health conditions and reducing the burden on healthcare systems.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 374.9 million |
| Forecasted Market Value (2034F) | US$ 810.9 million |
| Global Market Growth Rate (2024 to 2034) | 8.0% of CAGR |
| Diagnostics Segment Growth Rate (2024 to 2034) | 8.4% of CAGR |
| North America Market Share (2024) | 33.5% |
| East Asia Market Share (2024) | 19.1% |
| Key Companies Profiled | Thermo Fisher Scientific, Inc.; Neogen Corporation; Abbott; Sarstedt AG & Co.KG; Autogen, Inc.; Oasis Diagnostics; Porex; Salimetrics, LLC; Takara Bio, Inc.; Arcis Bio; Orasure Technologies |
What is Vitalizing the Demand for Saliva-based Screening Industry?
“The Non-invasive Nature of the Procedure and the Reduced Risk of Contamination is Vitalizing the Demand for Saliva-based Screening”
Non-invasive sampling has gained popularity recently due to its numerous advantages over traditional invasive methods. From a patient's perspective, saliva-based screening provides a more comfortable experience, eliminating the need for venipuncture or other invasive procedures. Saliva-based screening can be particularly beneficial for pediatric patients, elderly individuals, or those with needle phobias. The non-invasive nature of saliva collection may encourage more people to participate in screening programs, leading to higher compliance rates. It is crucial for public health initiatives and routine screenings where widespread participation is essential.
Saliva is rich in biomarkers that can provide valuable diagnostic information and insights into disease pathogenesis, making it an attractive source for researchers. The ease of sample collection and transport and the potential for rapid results make saliva-based testing an attractive option for developing point-of-care diagnostic devices. Additionally, the scalability of saliva-based screening makes it an ideal solution for mass screening programs, particularly during pandemics, where high-throughput testing is essential to control the spread of infectious diseases.
Manufacturers can also benefit from the scalability and user-friendliness of saliva-based screening, making it an appealing option for developing innovative diagnostic products. The ongoing research and technological advancements in saliva-based testing further underscore its potential as a versatile and patient-friendly diagnostic tool.
“Patient Convenience and its Applications in Infectious Disease Testing are other key Factors”
Ongoing advancements in technology and diagnostic methods have also improved the sensitivity and accuracy of saliva-based tests, boosting confidence in the reliability of results and making it a more viable option in healthcare. Public health initiatives, especially in response to pandemics or outbreaks, have further driven the adoption of saliva-based screening due to its efficiency, ease of use, and potential for large-scale testing.
Saliva-based screening has been widely explored for infectious disease testing, including detecting viruses such as SARS-CoV-2. The simplicity and less invasive nature of saliva testing can be crucial in managing and controlling the spread of infectious diseases. As the demand for saliva-based screening continues to evolve, new factors may emerge, but its potential to revolutionize healthcare screening and diagnostics must be addressed.
What are Some Lucrative Opportunities in the Saliva-based Screening Market?
“Ongoing Research expands Saliva-based Screening's Diagnostic potential from Personalized Medicine to Clinical Trials”
Ongoing research is identifying new biomarkers in saliva, which could expand the range of conditions diagnosed through saliva-based screening. With advancements in technology, saliva-based screening could contribute to the development of personalized medicine by allowing comprehensive biomarker profiling. Saliva-based screening could lead to treatments tailored to an individual's unique saliva profile, improving therapeutic outcomes. This is especially valuable in resource-limited settings or during public health emergencies, where quick and accurate diagnoses are essential.
Saliva-based screening can revolutionize how we diagnose and treat diseases, including autoimmune disorders, cardiovascular conditions, and neurodegenerative diseases. Integration of next-generation sequencing (NGS) and other high-throughput technologies could enhance the diagnostic accuracy and depth of information obtained from saliva samples. Saliva-based genomic analysis is another promising area of research. Integrating advanced genomic technologies, such as whole-genome sequencing, could uncover genetic information from saliva samples.
Application of mass spectrometry and other high-throughput proteomic techniques for in-depth profiling of saliva proteomes could enable a more comprehensive understanding of disease-related protein changes. Personalized medicine applications could be developed using saliva-based screening to predict individual medication responses and optimize drug therapies. Saliva-based assays could assess genetic variations influencing drug metabolism, efficacy, and potential adverse reactions, contributing to more effective and personalized treatment plans.
Saliva-based screening is gaining popularity in diagnostic laboratories for comprehensive disease profiling and population-scale screening, presenting an opportunity to enhance efficiency and reproducibility through the automation and standardization of saliva sample processing methodologies. For biopharmaceuticals and CROs, integrating saliva-based screening in clinical trials offers a non-invasive and patient-friendly approach to assess treatment responses and safety, making it a potential game-changer in patient monitoring, biomarker discovery, and pharmacogenomic studies.
Which are Some Threats Hindering the Saliva-based Screening Industry?
“Limited Biomarker Availability and Variability in Saliva Composition require ongoing efforts to ensure Reliable Results”
While saliva-based screening has shown promise in various areas, some critics argue that it may not be as sensitive or specific as traditional methods, especially for certain conditions. One of the key challenges in developing saliva-based tests is the limited availability of biomarkers. Not all biomarkers in blood or other bodily fluids are readily detectable in saliva, which may restrict the range of conditions that can be effectively screened using this approach.
Another challenge is ensuring the reliability of results. Saliva composition can vary between individuals and even within the same individual at different times, impacting test results' consistency and accuracy. Despite this challenge, significant progress has been made in establishing standardized protocols and validating the diagnostic accuracy of saliva-based tests. Regulatory bodies may require rigorous validation before approving these tests for widespread use.
“Need for increased Awareness, Regulatory Approval challenges, and Considerations regarding Cost-effectiveness compared to Traditional methods.”
There are many advantages, but there still needs to be more awareness and acceptance among the general population and healthcare professionals about the effectiveness of saliva-based screening. Educating healthcare providers and the public about the benefits of this method is critical for its widespread acceptance and adoption. Regulatory approval is one of the significant hurdles to integrating saliva-based tests into mainstream healthcare practices. Achieving regulatory approval for these tests can be lengthy, as stringent regulatory requirements may pose a challenge. The regulatory bodies must ensure these tests meet the necessary safety and efficacy standards before approval.
Another important consideration is the cost-effectiveness of saliva-based tests compared to traditional methods. The development, production, and implementation of these tests need significant investment, and if the costs associated with them are high, it may impact their affordability and accessibility.
“Ensuring Diagnostic Accuracy and Regulatory Challenges to Hinder the Market Growth”
Manufacturers need to address the issue of diagnostic accuracy and ensure the reliability of these tests compared to traditional methods. False positives or negatives could lead to scepticism among healthcare professionals, regulatory bodies, and the general public. Producers must focus on sensitivity and specificity to build trust in saliva-based screening. Moreover, regulatory challenges and approval processes can cause significant delays in introducing saliva-based tests into clinical practice.
Stricter regulatory requirements may limit the market's growth potential, impacting the ability of manufacturers to bring innovative saliva-based screening products to market. Key players must navigate these regulatory landscapes effectively to ensure the timely and widespread adoption of saliva-based screening. Staying competitive and improving the performance and cost-effectiveness of saliva-based screening will be crucial to overcoming market threats and maintaining a strong position in the healthcare industry.
Country-wise Insights
The saliva-based screening industry finds a considerable portion of its user base in North America and East Asia. North America is predicted to hold 33.5% of the worldwide market share in 2024. The market is expected to progress at a CAGR of 7.6% for the forecast period.
East Asia is the other region with a considerable share of the market. In 2024, the share for East Asia is tipped to be 19.1%. The market is expected to register a promising CAGR of 9.3% in East Asia over the forecast period.
What is Augmenting the Saliva-based Screening Industry in the United States?
“The COVID-19 Pandemic, Public Health Initiatives, and Patient preferences for Comfort propel the United States.”
| Attributes | Details |
|---|---|
| Market Value (2024E) | US$ 108 million |
| CAGR (2024 to 2034) | 7.5% |
| Projected Value (2034F) | US$ 224 million |
The value of the United States' saliva-based screening industry is estimated to be US$ 108 million in 2024. The market is expected to register a CAGR of 7.5% over the forecast period, reaching US$ 224 million by 2034.
Saliva-based screening in the United States has experienced significant growth and adoption in recent years, with several factors contributing to this trend. One of the primary drivers of this growth is the COVID-19 pandemic, which has accelerated the demand for non-invasive and comfortable testing alternatives. Public health agencies and initiatives in the United States have played a crucial role in promoting saliva-based testing for infectious and non-infectious diseases. Patient preferences for non-invasive testing methods have also fueled the demand for saliva-based screening, with patients increasingly opting for tests that offer a more comfortable and less intrusive experience.
Continuous advancements in technology, including molecular diagnostics and high-throughput screening techniques, have enhanced the sensitivity and specificity of saliva-based screening, boosting the confidence of healthcare professionals and researchers in the reliability of results. The integration of saliva-based screening with telehealth services has facilitated remote diagnostics and monitoring, becoming particularly relevant with the increased adoption of telehealth platforms in the United States. This has provided patients with convenient options for testing and consultation.
Why is the Demand for Saliva-based Screening Increasing steadily in the Chinese Market?
“Investments in Diagnostic Technology and Regulatory Facilitation Contributes to the Integration into the Healthcare System”
| Attributes | Details |
|---|---|
| Market Value (2024E) | US$ 36 million |
| CAGR (2024 to 2034) | 9.4% |
| Projected Value (2034F) | US$ 87 million |
The value of the Chinese market for saliva-based screening is estimated to be US$ 36 million in 2024. The market is expected to register a CAGR of 9.4% over the forecast period, reaching US$ 87 million by 2034.
Saliva tests for SARS-CoV-2 have gained popularity due to their non-invasive nature, ease of collection, and reduced requirement for skilled healthcare personnel. This has allowed for mass testing initiatives, especially in densely populated areas.
China's investments in research and development, advances in diagnostic technologies, and regulatory support have facilitated the integration of these screenings into the healthcare system.
Integrating saliva-based screening with telemedicine and digital health platforms enables remote testing and consultations, addressing healthcare needs in urban and rural areas. China's supportive government policies, regulations, and approvals for saliva-based screening have encouraged their development and commercialization, enhancing the accuracy and efficiency of screening.
Category-wise Insights
Why is the Diagnostics Segment Dominating the Saliva-based Screening Market?
| Attributes | Details |
|---|---|
| Segment Value (2024E) | US$ 292.1 million |
| CAGR (2024 to 2034) | 8.4% |
| Projected Value (2034F) | US$ 654.6 million |
Saliva-based screening is gaining popularity among patients, manufacturers, and producers who recognize the benefits of this non-invasive diagnostic method. The ease of sample collection and the versatility of saliva-based screening in diagnosing various health conditions have made it a preferred choice for manufacturers and producers looking for a reliable and accurate diagnostic tool.
Manufacturers and producers can now develop and produce these tests on a larger scale, making them more accessible and affordable for patients. This leads to a significant increase in demand for these tests. As more healthcare professionals, patients, and manufacturers recognize the benefits of saliva-based diagnostics, the demand for these tests will continue to grow.
Competitive Landscape
Key players in the saliva-based screening market include Thermo Fisher Scientific, Inc., Neogen Corporation, Abbott, Sarstedt AG & Co.KG, Autogen, Inc., Oasis Diagnostics, Porex, Salimetrics, LLC, Takara Bio, Inc., Arcis Bio, and Orasure Technologies.
Leading companies such as Molbio Diagnostics and Testi Technologies and innovative players like Salilistic have critical roles in introducing groundbreaking technologies. These advancements include the development of rapid point-of-care saliva testing devices, expanding diagnostic applications beyond infectious diseases, and integrating cutting-edge genomic and proteomic analyses. Key players continue to invest in research and development, focusing on refining diagnostic accuracy, exploring novel biomarkers, and expanding the applications of saliva-based screening.
Recent Advancements :
- On December 15, 2023, Goa-based Molbio Diagnostics partnered with Finland's Testi Technologies to commercialize PROMILLESS, a saliva-based self-test kit for measuring body alcohol content. The collaboration aimed to enhance accessibility and advance diagnostics.
- On August 28, 2023, researchers explored the potential of automated, saliva-based PCR testing for COVID-19 surveillance. A study on the medRxiv preprint server detailed implementing a PCR testing program in an educational institution.
- Launched on June 21, 2023, the world's first saliva-based pregnancy test, Salilistic, revolutionized pregnancy detection in the UK. Eliminating the need for urine marked a significant advancement in home pregnancy testing.
Segmentation of the Saliva-based Screening Market
-
By Product Type :
- Saliva Collection Kits
- Saliva Nucleic Acid Purification Kits,
- Saliva Based Detection Kits
-
By Purpose :
- Research Use Only
- Diagnostics
-
By Application :
- Infection Analysis/Detection (Non- COVID)
- Genomic Analysis
- Proteomics
- Pharmacogenomics
- Liquid biopsy
-
By End User :
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic and Research Institutes
- Biopharmaceuticals and CROs
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
- 5.1. Saliva collection kits/devices
- 5.2. Saliva nucleic acid purification kits
- 5.3. Saliva base detection kits
- 5.3.1. PCR based
- 5.3.2. Rapid kits
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Purpose
- 6.1. Research
- 6.2. Diagnostics
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
- 7.1. Infection Analysis/Detection
- 7.2. Genomic Analysis
- 7.3. Proteomics
- 7.4. Pharmacogenomics
- 7.5. Liquid biopsy
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
- 8.1. Hospitals & Clinics
- 8.2. Diagnostic laboratories
- 8.3. Academic & research institutes
- 8.4. Biopharmaceuticals & CRO’s
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. South Asia and Pacific
- 9.6. East Asia
- 9.7. Middle East and Africa
- 10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 17. Key Countries Market Analysis
- 18. Market Structure Analysis
- 19. Competition Analysis
- 19.1. Thermo Fisher Scientific
- 19.2. Hologic
- 19.3. Qiagen
- 19.4. Zymo Research Corporation
- 19.5. DNA Genotek Inc.
- 19.6. Invitek Molecular GmbH
- 19.7. Salimetrics, LLC.
- 19.8. BioChain Institute Inc.
- 19.9. Mawi DNA Technologies LLC
- 19.10. Cell Projects Ltd.
- 19.11. Kyodo International, Inc.
- 20. Assumptions & Acronyms Used
- 21. Research Methodology
List Of Table
Table 01: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 02: Global Market Volume (Units) Forecast by Region, 2019 to 2034
Table 03: Global Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 04: Global Market Volume (Units) Forecast by Product, 2019 to 2034
Table 05: Global Market Value (US$ Million) Forecast by Purpose, 2019 to 2034
Table 06: Global Market Volume (Units) Forecast by Purpose, 2019 to 2034
Table 07: Global Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 08: Global Market Volume (Units) Forecast by Application, 2019 to 2034
Table 09: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 10: Global Market Volume (Units) Forecast by End User, 2019 to 2034
Table 11: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 12: North America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 13: North America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 14: North America Market Volume (Units) Forecast by Product, 2019 to 2034
Table 15: North America Market Value (US$ Million) Forecast by Purpose, 2019 to 2034
Table 16: North America Market Volume (Units) Forecast by Purpose, 2019 to 2034
Table 17: North America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 18: North America Market Volume (Units) Forecast by Application, 2019 to 2034
Table 19: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 20: North America Market Volume (Units) Forecast by End User, 2019 to 2034
Table 21: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 22: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 23: Latin America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 24: Latin America Market Volume (Units) Forecast by Product, 2019 to 2034
Table 25: Latin America Market Value (US$ Million) Forecast by Purpose, 2019 to 2034
Table 26: Latin America Market Volume (Units) Forecast by Purpose, 2019 to 2034
Table 27: Latin America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 28: Latin America Market Volume (Units) Forecast by Application, 2019 to 2034
Table 29: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 30: Latin America Market Volume (Units) Forecast by End User, 2019 to 2034
Table 31: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 32: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 33: Western Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 34: Western Europe Market Volume (Units) Forecast by Product, 2019 to 2034
Table 35: Western Europe Market Value (US$ Million) Forecast by Purpose, 2019 to 2034
Table 36: Western Europe Market Volume (Units) Forecast by Purpose, 2019 to 2034
Table 37: Western Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 38: Western Europe Market Volume (Units) Forecast by Application, 2019 to 2034
Table 39: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 40: Western Europe Market Volume (Units) Forecast by End User, 2019 to 2034
Table 41: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 42: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 43: Eastern Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 44: Eastern Europe Market Volume (Units) Forecast by Product, 2019 to 2034
Table 45: Eastern Europe Market Value (US$ Million) Forecast by Purpose, 2019 to 2034
Table 46: Eastern Europe Market Volume (Units) Forecast by Purpose, 2019 to 2034
Table 47: Eastern Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 48: Eastern Europe Market Volume (Units) Forecast by Application, 2019 to 2034
Table 49: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 50: Eastern Europe Market Volume (Units) Forecast by End User, 2019 to 2034
Table 51: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 52: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034
Table 53: South Asia and Pacific Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 54: South Asia and Pacific Market Volume (Units) Forecast by Product, 2019 to 2034
Table 55: South Asia and Pacific Market Value (US$ Million) Forecast by Purpose, 2019 to 2034
Table 56: South Asia and Pacific Market Volume (Units) Forecast by Purpose, 2019 to 2034
Table 57: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 58: South Asia and Pacific Market Volume (Units) Forecast by Application, 2019 to 2034
Table 59: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 60: South Asia and Pacific Market Volume (Units) Forecast by End User, 2019 to 2034
Table 61: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 62: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034
Table 63: East Asia Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 64: East Asia Market Volume (Units) Forecast by Product, 2019 to 2034
Table 65: East Asia Market Value (US$ Million) Forecast by Purpose, 2019 to 2034
Table 66: East Asia Market Volume (Units) Forecast by Purpose, 2019 to 2034
Table 67: East Asia Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 68: East Asia Market Volume (Units) Forecast by Application, 2019 to 2034
Table 69: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 70: East Asia Market Volume (Units) Forecast by End User, 2019 to 2034
Table 71: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 72: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034
Table 73: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 74: Middle East and Africa Market Volume (Units) Forecast by Product, 2019 to 2034
Table 75: Middle East and Africa Market Value (US$ Million) Forecast by Purpose, 2019 to 2034
Table 76: Middle East and Africa Market Volume (Units) Forecast by Purpose, 2019 to 2034
Table 77: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 78: Middle East and Africa Market Volume (Units) Forecast by Application, 2019 to 2034
Table 79: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 80: Middle East and Africa Market Volume (Units) Forecast by End User, 2019 to 2034
List Of Figures
Figure 01: Global Market Value (US$ Million) by Product, 2024 to 2034
Figure 02: Global Market Value (US$ Million) by Purpose, 2024 to 2034
Figure 03: Global Market Value (US$ Million) by Application, 2024 to 2034
Figure 04: Global Market Value (US$ Million) by End User, 2024 to 2034
Figure 05: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 06: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 07: Global Market Volume (Units) Analysis by Region, 2019 to 2034
Figure 08: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 09: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 10: Global Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 11: Global Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 12: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 13: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 14: Global Market Value (US$ Million) Analysis by Purpose, 2019 to 2034
Figure 15: Global Market Volume (Units) Analysis by Purpose, 2019 to 2034
Figure 16: Global Market Value Share (%) and BPS Analysis by Purpose, 2024 to 2034
Figure 17: Global Market Y-o-Y Growth (%) Projections by Purpose, 2024 to 2034
Figure 18: Global Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 19: Global Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 20: Global Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 21: Global Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 22: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 23: Global Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 24: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 25: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 26: Global Market Attractiveness by Product, 2024 to 2034
Figure 27: Global Market Attractiveness by Purpose, 2024 to 2034
Figure 28: Global Market Attractiveness by Application, 2024 to 2034
Figure 29: Global Market Attractiveness by End User, 2024 to 2034
Figure 30: Global Market Attractiveness by Region, 2024 to 2034
Figure 31: North America Market Value (US$ Million) by Product, 2024 to 2034
Figure 32: North America Market Value (US$ Million) by Purpose, 2024 to 2034
Figure 33: North America Market Value (US$ Million) by Application, 2024 to 2034
Figure 34: North America Market Value (US$ Million) by End User, 2024 to 2034
Figure 35: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 36: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 37: North America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 40: North America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 41: North America Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 42: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 43: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 44: North America Market Value (US$ Million) Analysis by Purpose, 2019 to 2034
Figure 45: North America Market Volume (Units) Analysis by Purpose, 2019 to 2034
Figure 46: North America Market Value Share (%) and BPS Analysis by Purpose, 2024 to 2034
Figure 47: North America Market Y-o-Y Growth (%) Projections by Purpose, 2024 to 2034
Figure 48: North America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 49: North America Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 50: North America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 51: North America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 52: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 53: North America Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 54: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 55: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 56: North America Market Attractiveness by Product, 2024 to 2034
Figure 57: North America Market Attractiveness by Purpose, 2024 to 2034
Figure 58: North America Market Attractiveness by Application, 2024 to 2034
Figure 59: North America Market Attractiveness by End User, 2024 to 2034
Figure 60: North America Market Attractiveness by Country, 2024 to 2034
Figure 61: Latin America Market Value (US$ Million) by Product, 2024 to 2034
Figure 62: Latin America Market Value (US$ Million) by Purpose, 2024 to 2034
Figure 63: Latin America Market Value (US$ Million) by Application, 2024 to 2034
Figure 64: Latin America Market Value (US$ Million) by End User, 2024 to 2034
Figure 65: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 66: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 67: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 70: Latin America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 71: Latin America Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 72: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 73: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 74: Latin America Market Value (US$ Million) Analysis by Purpose, 2019 to 2034
Figure 75: Latin America Market Volume (Units) Analysis by Purpose, 2019 to 2034
Figure 76: Latin America Market Value Share (%) and BPS Analysis by Purpose, 2024 to 2034
Figure 77: Latin America Market Y-o-Y Growth (%) Projections by Purpose, 2024 to 2034
Figure 78: Latin America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 79: Latin America Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 80: Latin America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 81: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 82: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 83: Latin America Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 84: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 85: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 86: Latin America Market Attractiveness by Product, 2024 to 2034
Figure 87: Latin America Market Attractiveness by Purpose, 2024 to 2034
Figure 88: Latin America Market Attractiveness by Application, 2024 to 2034
Figure 89: Latin America Market Attractiveness by End User, 2024 to 2034
Figure 90: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 91: Western Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 92: Western Europe Market Value (US$ Million) by Purpose, 2024 to 2034
Figure 93: Western Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 94: Western Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 95: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 96: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 97: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 98: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 99: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 100: Western Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 101: Western Europe Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 102: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 103: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 104: Western Europe Market Value (US$ Million) Analysis by Purpose, 2019 to 2034
Figure 105: Western Europe Market Volume (Units) Analysis by Purpose, 2019 to 2034
Figure 106: Western Europe Market Value Share (%) and BPS Analysis by Purpose, 2024 to 2034
Figure 107: Western Europe Market Y-o-Y Growth (%) Projections by Purpose, 2024 to 2034
Figure 108: Western Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 109: Western Europe Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 110: Western Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 111: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 112: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 113: Western Europe Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 114: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 115: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 116: Western Europe Market Attractiveness by Product, 2024 to 2034
Figure 117: Western Europe Market Attractiveness by Purpose, 2024 to 2034
Figure 118: Western Europe Market Attractiveness by Application, 2024 to 2034
Figure 119: Western Europe Market Attractiveness by End User, 2024 to 2034
Figure 120: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 121: Eastern Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 122: Eastern Europe Market Value (US$ Million) by Purpose, 2024 to 2034
Figure 123: Eastern Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 124: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 125: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 126: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 127: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 128: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 129: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 130: Eastern Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 131: Eastern Europe Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 132: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 133: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 134: Eastern Europe Market Value (US$ Million) Analysis by Purpose, 2019 to 2034
Figure 135: Eastern Europe Market Volume (Units) Analysis by Purpose, 2019 to 2034
Figure 136: Eastern Europe Market Value Share (%) and BPS Analysis by Purpose, 2024 to 2034
Figure 137: Eastern Europe Market Y-o-Y Growth (%) Projections by Purpose, 2024 to 2034
Figure 138: Eastern Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 139: Eastern Europe Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 140: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 141: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 142: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 143: Eastern Europe Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 144: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 145: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 146: Eastern Europe Market Attractiveness by Product, 2024 to 2034
Figure 147: Eastern Europe Market Attractiveness by Purpose, 2024 to 2034
Figure 148: Eastern Europe Market Attractiveness by Application, 2024 to 2034
Figure 149: Eastern Europe Market Attractiveness by End User, 2024 to 2034
Figure 150: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 151: South Asia and Pacific Market Value (US$ Million) by Product, 2024 to 2034
Figure 152: South Asia and Pacific Market Value (US$ Million) by Purpose, 2024 to 2034
Figure 153: South Asia and Pacific Market Value (US$ Million) by Application, 2024 to 2034
Figure 154: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034
Figure 155: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 156: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 157: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 158: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 159: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 160: South Asia and Pacific Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 161: South Asia and Pacific Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 162: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 163: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 164: South Asia and Pacific Market Value (US$ Million) Analysis by Purpose, 2019 to 2034
Figure 165: South Asia and Pacific Market Volume (Units) Analysis by Purpose, 2019 to 2034
Figure 166: South Asia and Pacific Market Value Share (%) and BPS Analysis by Purpose, 2024 to 2034
Figure 167: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Purpose, 2024 to 2034
Figure 168: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 169: South Asia and Pacific Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 170: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 171: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 172: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 173: South Asia and Pacific Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 174: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 175: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 176: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034
Figure 177: South Asia and Pacific Market Attractiveness by Purpose, 2024 to 2034
Figure 178: South Asia and Pacific Market Attractiveness by Application, 2024 to 2034
Figure 179: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034
Figure 180: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 181: East Asia Market Value (US$ Million) by Product, 2024 to 2034
Figure 182: East Asia Market Value (US$ Million) by Purpose, 2024 to 2034
Figure 183: East Asia Market Value (US$ Million) by Application, 2024 to 2034
Figure 184: East Asia Market Value (US$ Million) by End User, 2024 to 2034
Figure 185: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 186: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 187: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 188: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 189: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 190: East Asia Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 191: East Asia Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 192: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 193: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 194: East Asia Market Value (US$ Million) Analysis by Purpose, 2019 to 2034
Figure 195: East Asia Market Volume (Units) Analysis by Purpose, 2019 to 2034
Figure 196: East Asia Market Value Share (%) and BPS Analysis by Purpose, 2024 to 2034
Figure 197: East Asia Market Y-o-Y Growth (%) Projections by Purpose, 2024 to 2034
Figure 198: East Asia Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 199: East Asia Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 200: East Asia Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 201: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 202: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 203: East Asia Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 204: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 205: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 206: East Asia Market Attractiveness by Product, 2024 to 2034
Figure 207: East Asia Market Attractiveness by Purpose, 2024 to 2034
Figure 208: East Asia Market Attractiveness by Application, 2024 to 2034
Figure 209: East Asia Market Attractiveness by End User, 2024 to 2034
Figure 210: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 211: Middle East and Africa Market Value (US$ Million) by Product, 2024 to 2034
Figure 212: Middle East and Africa Market Value (US$ Million) by Purpose, 2024 to 2034
Figure 213: Middle East and Africa Market Value (US$ Million) by Application, 2024 to 2034
Figure 214: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034
Figure 215: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 216: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 217: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 218: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 219: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 220: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 221: Middle East and Africa Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 222: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 223: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 224: Middle East and Africa Market Value (US$ Million) Analysis by Purpose, 2019 to 2034
Figure 225: Middle East and Africa Market Volume (Units) Analysis by Purpose, 2019 to 2034
Figure 226: Middle East and Africa Market Value Share (%) and BPS Analysis by Purpose, 2024 to 2034
Figure 227: Middle East and Africa Market Y-o-Y Growth (%) Projections by Purpose, 2024 to 2034
Figure 228: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 229: Middle East and Africa Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 230: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 231: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 232: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 233: Middle East and Africa Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 234: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 235: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 236: Middle East and Africa Market Attractiveness by Product, 2024 to 2034
Figure 237: Middle East and Africa Market Attractiveness by Purpose, 2024 to 2034
Figure 238: Middle East and Africa Market Attractiveness by Application, 2024 to 2034
Figure 239: Middle East and Africa Market Attractiveness by End User, 2024 to 2034
Figure 240: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
- FAQs -
How big is the Saliva-based Screening Market?
The global saliva-based screening market size is estimated to be US$ 374.9 million in 2024 and is predicted to grow to US$ 810.9 million in 2034.
What is the Adoption Growth Projection for the Saliva-based Screening Market?
The adoption growth of saliva-based screening is projected to rise at a CAGR of 8.0% through 2034.
Which Segment is dominating the Saliva-based Screening Market?
The diagnostic segment dominates the saliva-based screening industry.
Who are the Key Players in the Saliva-based Screening Market?
Some key players are Thermo Fisher Scientific, Inc., Neogen Corporation, Abbott, Sarstedt AG & Co.KG, and Autogen, Inc.
Which Country in East Asia is ruling the Saliva-based Screening Market?
China dominates the saliva-based screening industry in East Asia.
Related Reports
Saliva-based Screening Market